PEDIATRIX: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PEDIATRIX
Largest movements
- Current investments +€1,709
up €1,709 (+1.2%), from €143,636 to €145,345
- Other debts +€2,215
up €2,215 (+48.9%), from €4,528 to €6,743
- Financial income -€9,928
down €9,928 (-74.9%), from €13,255 to €3,327
- Financial charges +€1,642
up €1,642 (+1055.7%), from €156 to €1,797
- Gross operating margin -€195
down €195 (-10.1%), from -€1,927 to -€2,122
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €145,440 | €146,596 | +€1,156 | +0.8% |
| Current assets | 29/58 | €145,440 | €146,596 | +€1,156 | +0.8% |
| Current investments | 50/53 | €143,636 | €145,345 | +€1,709 | +1.2% |
| Cash at bank and in hand | 54/58 | €1,803 | €1,251 | -€553 | -30.6% |
| Total equity and liabilities | 10/49 | €145,440 | €146,596 | +€1,156 | +0.8% |
| Equity | 10/15 | €140,912 | €139,853 | -€1,059 | -0.8% |
| Contributions | 10/11 | €30,937 | €30,937 | = | 0.0% |
| Profit (loss) carried forward | 14 | €109,975 | €108,916 | -€1,059 | -1.0% |
| Amounts payable | 17/49 | €4,528 | €6,743 | +€2,215 | +48.9% |
| Amounts payable within one year | 42/48 | €4,528 | €6,743 | +€2,215 | +48.9% |
| Other amounts payable | 47/48 | €4,528 | €6,743 | +€2,215 | +48.9% |
| Other operating charges | 640/8 | €451 | €465 | +€14 | +3.2% |
| Gross operating margin | 9900 | -€1,927 | -€2,122 | -€195 | -10.1% |
| Operating profit (loss) | 9901 | -€2,378 | -€2,587 | -€209 | -8.8% |
| Financial income | 75/76B | €13,255 | €3,327 | -€9,928 | -74.9% |
| Recurring financial income | 75 | €13,255 | €3,327 | -€9,928 | -74.9% |
| Financial charges | 65/66B | €156 | €1,797 | +€1,642 | +1055.7% |
| Recurring financial charges | 65 | €156 | €1,797 | +€1,642 | +1055.7% |
| Profit (loss) for the period before taxes | 9903 | €10,721 | -€1,057 | -€11,778 | |
| Income taxes | 67/77 | €4 | €2 | -€2 | -54.0% |
| Profit (loss) for the period | 9904 | €10,717 | -€1,059 | -€11,776 | |
| Profit (loss) for the period to be appropriated | 9905 | €10,717 | -€1,059 | -€11,776 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.